From Traditional Biomarkers to Transcriptome Analysis in Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|5|1|29-38

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.5, Iss.1, 2005-02, pp. : 29-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Transcriptome Analysis in Drug Development (Executive Editor: William V. Williams)]

By  

Current Molecular Medicine, Vol. 5, Iss. 1, 2005-02 ,pp. : 1-2

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development

By  

Current Molecular Medicine, Vol. 10, Iss. 6, 2010-08 ,pp. : 596-607

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Transcriptome Analysis to Clinical Pharmacology Studies

By  

Current Molecular Medicine, Vol. 5, Iss. 1, 2005-02 ,pp. : 65-82

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Transcriptome Analysis in Pre-Clinical Toxicology

By  

Current Molecular Medicine, Vol. 5, Iss. 1, 2005-02 ,pp. : 53-64

Bentham Science Publishers

Access to resources Recommend Favorite

The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development

By  

Current Molecular Medicine, Vol. 16, Iss. 4, 2016-05 ,pp. : 353-393

Bentham Science Publishers

Access to resources Recommend Favorite